FDA limits J&J COVID-19 vaccine authorization due to blood clot risk

Asking Questions - Part Twenty-Three

I will discuss this in more detail tomorrow, but I do believe that I am alive today because I questioned putting something into my body. I was a week away from going into the Johnson & Johnson trial in January 2021 and by the graces of God tonight confirmed that I made the right decision by canceling that appointment.

U.S. FDA @US_FDA

Today, we limited the authorized use of the Janssen #COVID19 Vaccine to those 18+ for whom other auth/approved vaccines are not accessible or clinically appropriate, & to those who elect Janssen because they would otherwise not receive a COVID vaccine. go.usa.gov/xudMH

The Associated Press @AP

U.S. regulators strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots. The FDA said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s.

apne.wsFDA restricts J&J’s COVID-19 vaccine due to blood clot riskWASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or sp…

Justin Hart @justin_hart

BREAKING! The day after a JAMA paper publishes significant signal evidence of increased risk for J&J post-vaccine Guillain-Barré Syndrome adverse reaction the FDA takes it away for people under 18. cnn.com/2022/05/05/hea… More vaccine updates here!

covidreason.substack.comCritical Vaccine UpdatesWe’re hoping to provide you an update on tomorrow’s podcast on some critical updates around recent vaccines studies. Listen to us on the Callin website, Apple iTunes, or Spotify. First, there are MULTIPLE viral tweets and posts going around about recently released documents from Pfizer.